EMA’s New Medicines Safety Chief Takes Charge Of Packed Agenda

Swedish regulator Ulla Wändel Liminga, the incoming chair of the European Medicines Agency’s Pharmacovigilance Committee, will oversee a number of projects including those she was already with such as those related to the safety of medicines during pregnancy and breastfeeding.

Testing, verification and determining pharmaceutical counterfeiting or fakes of medicines and medicinal substance quality concept. Pharmaceutical expert from checks number of medicine compliance
The PRAC is responsible for monitoring the safety of human medicines in the EU • Source: Shutterstock

Ulla Wändel Liminga, the newly elected chair of the European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC), will be overseeing a number of activities in the committee’s 2024 work plan as she assumes her role in September.

There are nearly three dozen activities listed in the PRAC’s 2024 work plan, a number of which are yet...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Europe

  • EU Biosimilar Filings, Opinions And Approvals

     
    • By 

    <p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>

  • EU Pharma Reform: What You Need to Know Now

     

    As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.

  • New EU Approvals

    <p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>

More from Geography